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Regulationactin-binding regulatory proteins, are present in muscle and non-muscle cells.
Multiple tropomyosin (TM) isoforms differ in actin afﬁnity and regulatory properties, but little is known
about the molecular bases of these differences. The C-terminus of actin stabilizes contacts between actin
subunits in the ﬁlament and interacts with myosin and regulatory proteins. The goal of this work was to
reveal how structural changes in actin and differences between TM isoforms affect binding between these
proteins and affect thin ﬁlament regulation. Actin proteolytically truncated by three C-terminal amino acids
exhibited 1.2–1.5 fold reduced afﬁnity for non-muscle and smooth muscle tropomyosin isoforms. The
truncation increased the cooperativity of myosin S1-induced tropomyosin binding for short tropomyosins
(TM5a and TM1b9a), but it was neutral for long isoforms (smTM and TM2). Actin modiﬁcation affected
regulation of actomyosin ATPase activity in the presence of all tropomyosins by shifting the ﬁlament into a
more active state. We conclude that the integrity of the actin C-terminus is important for actin–tropomyosin
interactions, however the increased afﬁnity of tropomyosin binding in the S1-induced state of the ﬁlament
appears not to be involved in the tropomyosin isoform-dependent mechanism of the actomyosin ATPase
activation.
© 2008 Elsevier B.V. Open access under CC BY license.1. IntroductionTropomyosins (TMs) are a family of regulatory proteins closely
associated with the actin ﬁlament. All TMs are two-chained α-helical
coiled-coil proteins thatbindalongbothsidesof theactinﬁlament.While
bound to F-actin TM molecules form long, continuous strands, due to
strong end-to-end interactions. Tropomyosins control muscle contrac-
tion and motility of non-muscle cells through regulation of the thin
ﬁlament interactions with myosin motors and actin-binding proteins.
The isoforms bind to actin with a wide range of afﬁnities and exhibit
different regulatorymechanisms foractinactivatedmyosinATPase [1–5].
During development TM isoforms are differentially expressed and
sorted to speciﬁc cellular compartments. The mechanism of isoform
sorting is complicated and not well understood. Gunning and
colleagues [4,5] suggested that the isoforms are driven to their ﬁnal
cellular destinations by afﬁnity of TMs for speciﬁc actin structures.
Studies on actin modiﬁed by site-directed mutagenesis [6–9] or
limited proteolysis [10] revealed that the interactions between TM and
actin involve direct contacts with charged surface residues as well as
allosteric structural transitions within actin itself. It is well established
that the afﬁnity of TMs for actin is deﬁned by isoform-speciﬁc8 52 3419184.
ka).
 license.sequences of TM encoded by alternative exons (reviewed in [1,3]).
Particularly important are the ends, as the end-to-end overlap greatly
increases afﬁnity of TMs for actin [11–13]. The process of thin ﬁlament
assembly is complex and cooperative. Initial binding of TM molecules
to an isolated site on the actin ﬁlament, where no TM–TM contacts
take place, is followed by binding to singly and doubly contiguous
binding sites, with both TM termini forming end-to-end contacts
except at the ﬁlament ends [11]. An increase in the afﬁnity occurs
when TM binds to an adjacent site and it is thought to be caused by
direct contacts between adjacent TM molecules and by conforma-
tional changes within actin itself [14]. However, the mechanism of
TM–actin interaction is not fully understood.
Using actin proteolytically modiﬁed by selective removal of three
C-terminal amino acids (actin−3), we have recently shown that
distortion of the actin structure within the C-terminal segment affects
actin interactions with skeletal α-TM, but the effect differs depending
on the state of the thin ﬁlament activation [15]. The analysis was done
in three thin ﬁlament activation states — blocked, closed and open,
which were proposed by McKillop and Geeves [16] on the basis of the
effect that TM and troponin (±Ca2+) exert on myosin binding to the
regulated thin ﬁlament. In striated muscle the catalytic states
correlate well with structural states visualized by three-dimensional
reconstructions of electron microscopic images of the thin ﬁlaments,
in agreement with the steric blocking mechanism of actin–myosin
Fig. 1. Schematic illustration of the α-TM variants used in this work. All isoforms are
expressed in smoothmuscle and non-muscle cells except for the chimeric TM (TM1b9a)
for which no natural counterpart has been found. The TM1b9a differs from TM5a only in
the sequence of C-terminus that is encoded by striated muscle-speciﬁc exon 9a. Boxes
represent TM regions encoded by exons labeled respectively on top of the schemes. The
proteins with N-termini encoded by exons 1a and 1b belong respectively to long and
short classes of TM. The C-terminal sequences are encoded either by striated muscle
speciﬁc exon 9a or constitutive exon 9d. Third region of difference is encoded either by
constitutive exon 2b or smooth muscle-speciﬁc 2a. The alternative exons expressed in
TM isoforms are represented by ﬁlled boxes (exon 1a-white dotted, 1b-black dotted, 2a-
hatched, 2b-checked, 9a-vertical bars, 9d-horizontal bars).
1 In the original paper this formula has been printed with a typographical error.
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and non-muscle cells do not always follow the same pattern in terms
of the function–structure relationships. For example, smooth muscle
TM was a better activator of actin-activated myosin S1 ATPase than
skeletal muscle TM [19–21], but its location on actin was closer to a
position which for skeletal TM was deﬁned as the blocked state [22].
This shows that in case of smooth muscle TM steric blocking cannot
explain the mechanism of actin ﬁlament regulation [21].
The actin C-terminus is an important region of the molecule
involved in forming an interface between actin monomers within
the ﬁlament and between actin and several actin-binding proteins
(reviewed in [23]). Conformational changes in this region can be
transmitted to distant regions of the molecule and affect interac-
tions with TM. Local and distant effects of the C-terminal
truncation on actin ﬁlament structure and dynamics are well
characterized [24–26]. Therefore we used truncated actin as a
model of conformationally altered actin to study the binding
modes of TM isoforms in thin ﬁlament activation states. To
examine the effects of actin conformational changes from the TM
point of view, we selected TMs with isoform-dependent sequence
combinations. We observed that modiﬁcation of actin slightly
affected parameters of TMs binding to actin alone, but only short
TM isoforms binding was affected by actin truncation when the
ﬁlament was activated by rigor-bound myosin heads. This indicates
that structural changes associated with actin modiﬁcation can
modulate interactions with TM in isoform-dependent manner. This
might underly the mechanism of TM isoforms sorting to different
cellular compartments. However, regulation of actomyosin ATPase
by TM isoforms does not seem to depend on the afﬁnity of TMs to
actin in the activated state. We conclude that in the presence of
TM the actin C-terminus is involved in maintaining the ﬁlament in
an inhibited state. Once the C-terminus is removed, the ﬁlament is
shifted into a more active state. Preliminary results of this work
were reported earlier [27].
2. Materials and methods
2.1. Protein preparation
Actin was isolated from chicken pectoral muscle acetone powder
according to the method of Spudich and Watt [28]. Actin−3, devoid ofthe three C-terminal amino acids, was prepared by trypsinolysis of G-
actin in which tightly bound Ca2+had been exchanged for Mg2+[25].
This method allows for speciﬁc removal of three residues (Lys373,
Cys374 and Phe375) from the actin C-terminus.
The four tropomyosin isoforms selected for this study were
products of the ratα-TM gene (TPM1). Regions of sequence differences
are described in the Fig. 1 legend. The isoforms were expressed in E.
coli strain BL21(DE3) transformed with rat α-TM cDNA cloned into
pET11d (Novagene, Houston, TX), as described in [29]. The cDNA
clones were the gift of Dr. S. Hitchcock-DeGregori. The proteins were
puriﬁed from bacteria according to the protocol described earlier [29].
All isoforms were unacetylated at the N terminus.
Myosin S1 was prepared by papain digestion of chicken pectoral
muscle myosin according to Margossian and Lowey [30].
The concentration of actinwas determined spectrophotometrically
at 290 nm using an extinction coefﬁcient of 0.63 for 0.1% actin, MW
42,000. The concentration of C-terminally truncated actin was
determined densitometrically as described in [15]. Myosin S1
concentration was calculated from an extinction coefﬁcient of 0.83
at 280 nm (0.1%) and protein MW 130,000. Concentrations of
recombinant TMs were determined by the differential absorption
spectra of tyrosine (refs. in [29]).
2.2. Actin binding assay
Tropomyosin binding to actin was studied by a cosedimentation
assay as described earlier [29] with modiﬁcations as in [15]. The
assay samples were composed of 5 μM ﬁlamentous F-Mg-actin and
TM at concentrations varying from 0.2 to 10 μM. For smTM, TM2
and TM1b9a actin binding buffer contained 5 mM imidazole, pH 7.0,
1 mM DTT, 150 mM NaCl and 2 mM MgCl2. Because TM5a binds
very strongly to actin [29], actin binding of this isoform was difﬁcult
to measure in the above conditions. To make the analysis possible,
the concentrations of NaCl and MgCl2 were reduced to 30 and
0.5 mM, respectively. Protein mixtures were centrifuged for 1 h at
40,000 rpm in Beckman rotor 42.2. The composition of the proteins
in pellets and the amount of free TM left in supernatant were
examined on 10% SDS-PAGE. The gels stained with Coomassie Blue
were scanned with Plustek OpticPro ST12 and quantitated using
EasyDens (Cortex Nova, Bydgoszcz, Poland) software. The TM bound
to actin was calculated as the TM/actin band intensity ratio
normalized to the maximum ratio reached at saturation. The
concentration of unbound TM was calculated from intensities of
TM in supernatant using a standard curve constructed from the
same TM isoform. The apparent association constant (Kapp) of TM to
actin was calculated by ﬁtting the experimental data to Hill equation
(Eq. (1)) in SigmaPlot (Systat Software Inc. San Jose, CA).
v = n TM½ αHKapp=1 + TM½ α
H
Kα
H
app ð1Þ
where v=fraction maximal TM binding to actin, n=maximal TM
bound, [TM]=free [TM], and αH=cooperativity coefﬁcient.
The McGhee and von Hippel equation (Eq. (2)) was also used to
calculate the equilibrium constant for the association of TM with an
isolated binding site (K0) and equilibrium constant for moving TM
from an isolated binding site to a singly contiguous binding site (ω), as
described by the authors [31]1.
v=c = K0 1−nvð Þ 2ω−1ð Þ 1−nvð Þ + v−R2 ω−1ð Þ 1−nvð Þ
 n−1 1− n + 1ð Þv + R
2 1−nvð Þ
 2
ð2Þ
where,
R={[1− (n+1) v]2+4 ωv (1−nv)}1/2; v=the number of mol of TM
bound per mol of actin, n=stoichiometry of TM binding to actin, and
239R. Skórzewski et al. / Biochimica et Biophysica Acta 1794 (2009) 237–243c=the concentration of free TM. The binding data were analyzed
by ﬁtting the experimental points to the Eq. (2) using non-linear
regression software Scientists from MicroMath Scientiﬁc Software
Inc., (Saint Louis, Mo) in which χ2-function between experimental
and theoretical values of a mathematical model is minimized. The
character of the curve generated by the Eq. (2) is shown in Fig. 2.
2.3. S1-induced binding of TM to actin
Tropomyosin binding to actin induced by myosin S1 was
analyzed by cosedimentation as described in [15]. Samples of
5 μM F-Mg-actin and 1 μM TM were titrated with S1 added to
ﬁnal concentrations between 0 and 6 μM. TMs were assayed under
conditions unfavourable for binding of TM to actin alone: 5 mM
imidazole pH 7.0, 30 mM NaCl, 0.5 mM MgCl2 and 1 mM DTT. In the
presence of TM5a, the NaCl concentration was lowered to 12 mM.
After centrifugation (1 h at 40,000 rpm, 20 °C in Beckman rotor
42.2), the proteins cosedimented with F-actin were separated by
electrophoresis on 12% SDS gels and analyzed densitometrically.
Saturation curves were plotted as TM/actin and S1/actin bands
intensity ratios, normalized to the values reached at maximal
binding, versus the S1/actin molar ratio. The number of S1 bound
per actin that was required for half maximal saturation of actin
ﬁlament with TM was calculated by ﬁtting in SigmaPlot modiﬁed
Hill equation to the experimental data:
v = n X½ αHKαHapp=1 + X½ α
H
Kα
H
app
 
+ C ð3Þ
where v=TM/actin density ratio, [X]=S1/actin molar ratio, C=TM/
actin density ratio at 0 S1 concentration. The S1/actin molar ratio
required for half maximal saturation of actin with TM was calculated
as 1/K. The maximal TM/actin ratio was the same for both F-actin−3
and native actin, indicative of complete saturation.
2.4. Actomyosin MgATPase
Myosin S1 ATPase activity was measured in 30 mM NaCl,
5 mM imidazole, pH 7.0, 2 mM MgCl2, 1 mM DTT at 0.38 μM
S1with actin concentrations varying between 5 and 20 μM. TM,
when present, was added to actin stock solution at equal molar
concentrations. The reaction was initiated by adding MgATP to
5 mM and stopped after 20 min. with 3.3% SDS and 30 mM EDTA.Fig. 2. Binding of smTM to native F-actin and evaluation of the association constant Ko,
cooperativity ω, and binding stoichiometry n, using McGhee and von Hippel approach.
Solid line represents the binding function (2) computed with the optimal parameters
obtained from non-linear regression analysis. v is the number of mol of tropomyosin
bound per mol of actin, c is the concentration of free tropomyosin. For details see
Materials and methods.The amount of liberated phosphate was determined colorime-
trically [32].
3. Results
3.1. Binding of TM isoforms to actin
To examine whether conformational changes in the C-terminal
region of actin inﬂuence binding of TM isoforms, we compared
afﬁnities of α-TM isoforms to native and C-terminal truncated actin
in direct cosedimentation assay. Since differences in sequence
among the isoforms are limited to well deﬁned regions (Fig. 1),
we assumed that any signiﬁcant differences between native actin
and actin−3 binding would reveal recognition of the speciﬁc TM
sequence by actin.
Removal of three residues from actin C-teminus had a small
effect on the binding of each of the TM isoforms used (Fig. 3). The
equilibrium binding constants (Kapp) obtained by ﬁtting the
experimental points to the Hill equation (Eq. 1) are summarized in
Table 1 and show that actin truncation reduced the isoforms' afﬁnity
by a factor ranging between 1.2 and 1.5. The cooperativity coefﬁcient
(αH) of TMs binding to F-actin−3 was slightly greater than that for
the binding to F-actin. The only TM isoform which bound to F-
actin−3 with lower cooperativity was TM2 (Table 1). This might
suggest that actin modiﬁcation affects the afﬁnity of TM either
through changing direct TM–actin contacts or through distortion of
binding cooperativity.
Adapting theMcGhee and von Hippel model for ligand binding to a
linear lattice [33], we analyzed the effect of actin truncation on TM
afﬁnity to an isolated binding site and an equilibrium constant for
moving TM from an isolated binding site to a singly contiguous
binding site, which is a measure of binding cooperativity [11,31,34].
The analysis revealed that in the case of three isoforms (smTM,
TM1b9a and TM5a) the afﬁnity to an isolated binding site (Ko) was
reduced and binding to a contiguous site (ω) was increased by
modiﬁcation of the actin C-terminus. The TM2 bound to truncated
actin with a binding coefﬁcient Ko similar to that of native actin and
with the lower cooperativity (Table 1). Assuming that binding to an
isolated site reﬂects direct TM–actin contacts and cooperativity
coefﬁcient reﬂects long-range interactions induced by the TM that is
already bound, our results suggest the C-terminal region can affect the
binding of tropomyosins through both direct contacts and/or long-
range interactions. We then asked whether the removal of C-terminal
residues affects also TM binding in the fully active myosin-induced
state and, if it does, what is the response of TM isoforms to the actin
modiﬁcation.
3.2. S1-induced binding of TM isoforms
The strong, rigor binding of myosin heads to actin is required for
full activation of the thin ﬁlament [16]. In the activated state the
afﬁnity of TM for actin strongly increases [35,36]. The cooperativity of
themyosin S1-induced shift of the ﬁlament into the active state can be
assessed in an assay developed by Eaton [35], in which TM binding to
actin is analyzed under conditions in which binding of TM alone is
poor, but it increases upon the binding of myosin heads to actin. It is
thought that S1 induces conformational change in actin, which
facilitates binding of TM with high afﬁnity. The lower the number of
rigor-bound S1 that are required for actin saturation with TM, the
greater the cooperativity [29].
Actin C-terminal modiﬁcation had different effects on S1-induced
binding of the long and short TM isoforms. While long isoforms
(smTM and TM2) were not sensitive to actin truncation and bound to
both types of actin with the same cooperativity, the short TMs,
TM1b9a and TM5a, boundmore easily tomodiﬁed than to native actin
(Fig. 4). The numbers given in Table 2 illustrate the cooperativity of
Fig. 3. Effect of actin truncation on its afﬁnity for tropomyosin isoforms. Binding of smTM (A), TM2 (B), TM1b9a (C), and TM5a (D) to native F-actin (closed symbols) or F-actin−3 (open
symbols) was assayed as described in Materials and methods. Conditions: 5 mM imidazole, 1 mM DTT, 150 mM NaCl, 2 mM MgCl2, with pH adjusted to 7.0, in the case of D)
concentrations of NaCl and MgCl2 were respectively 30 and 0.5 mM. Data are from 3 to 5 independent experiments. Binding curves were drawn by ﬁtting the experimental points to
Hill equation (Eq. 1); (solid line) native F-actin; (dashed line) F-actin−3.
Table 1
Parameters of TM isoforms binding to native F-actin and truncated F-actin−3
TM Kapp (μM−1)⁎ αH⁎ Ko (μM−1)† ω †
isoform: F-actin F-
actin−3
F-actin F-actin−3 F-
actin
F-
actin−3
F-
actin
F-
actin−3
smTM 1.22
±0.04
1.01
±0.02
2,08
±0,19
2.45
±0.19
0.041 0.023 25.3 40.9
TM2 1.89
±0.07
1.36
±0.05
2.73
±0.32
2.33
±0.24
0.025 0.023 64.5 51.1
TM1b9a 3.80
±0.26
3.20
±0.16
1.70
±0.25
2.30
±0.26
0.108 0.082 24.1 33.2
TM5a 3.68
±0.69
2.46
±0.37
1.60
±0.28
2.00
±0.35
0.21 0.089 16.1 25.6
In this and the following tables the data obtained were averaged from 3 to 5
independent experiments done for each TM isoform;±SE. The data in the binding
isotherms in Fig. 3 were analyzed using two methods to obtain values for the afﬁnity
and cooperativity. Data obtained by ﬁtting the experimental points to Hill equation (⁎)
(Eq. 1) or to McGhee and von Hippel equation (†) (Eq. 2). The equations are given in
Materials and methods section. Conditions: 5 mM imidazole, pH 7.0, 1 mMDTT,150mM
NaCl, 2 mM MgCl2 (or 30 mM NaCl, 0.5 mM MgCl2 for TM5a).
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non-linear regression ﬁtting that averaged experimental points to Eq.
3 (see Materials and methods).
The S1 concentration for half-maximal saturation of F-actin−3 with
TM5a was half that of native actin (p=0.002). The binding of
approximately one myosin head per segment of six actins (which
interacts with one TM molecule) was necessary for full saturation of
native actin with TM5a, whereas saturation of truncated actin was
completed when only 0.5 myosin heads per six actins (or per one TM)
were bound. The differences in S1-induced TM binding were not
caused by altered S1 binding, because actin C-terminal modiﬁcation
did not affect S1 binding to actin (Fig. 4D, inset). The parameters of S1-
induced binding of TM1b9a were similar to the parameters obtained
for TM5a (Table 2). However, the statistical signiﬁcance of the
difference between native and truncated actin in the case of
TM1b9a is ambiguous, as the t-test generated p=0.07, which
minimally exceeds the threshold of signiﬁcance.
3.3. Regulation of actin-activated myosin S1 ATPase activity
Since the cooperativity with which myosin S1 induces TM binding
to actin is a measure of the thin ﬁlament tendency to switch into the
active state [29], one would expect that truncated actin complexed
with short TMs would activate myosin S1 ATPase more readily than in
complex with long TM isoforms. To verify this hypothesis we analyzed
the effect of actin truncation on the regulation of actin-activated
myosin S1 ATPase by tropomyosin isoforms.
The ATPase activity was analyzed at constant S1 concentration by
increasing actin or actin–TM concentrations. Fig. 5 illustrates double
reciprocal plots of actin-activated S1 ATPase activity for representative
tropomyosins (TM5a and TM2). Because in the conditions used in this
assay the S1 enzymatic activity was far below saturation, we used
double reciprocal plots rather than saturation curves. This generated
an elevated standard error for the calculated ATPase parameters, KMand Vmax, despite the small experimental error in each measured
point. In agreement with earlier observations [15,24], the removal of
C-terminal residues from actin reduced maximal rate of S1 ATPase
(Vmax), whereas the Michaelis–Menten constant (KM) was not affected
(Table 3). Saturating the ﬁlaments with the TM isoforms did not
change the KM. In contrast, the effects on Vmax depended on the TM
isoforms (Table 3). The TM5a activated the ATPase, which agrees with
a previous report showing that this isoform is very efﬁcient in the
activation of thin ﬁlament [37]. The other TM isoforms (TM2, smTM
and TM1b9a) inhibited the ATPase activity by lowering Vmax.
In order to compare effects of the isoforms to regulate the ATPase
in complexes with normal andmodiﬁed actin, we normalized the data
for each type of actin by dividing Vmax observed in the presence of TM
Fig. 4.Myosin S1-induced binding of TM to native and truncated actin. Binding of smTM (A), TM2 (B), TM1b9a (C), and TM5a (D) to native F-actin (closed symbols) and F-actin−3 (open
symbols) was assayed under the following conditions: 5 mM imidazole, pH 7.0, 30 mM (or 12 mM for TM5a) NaCl, 0.5 mMMgCl2, 1 mM DTT. S1/actin is a volumetric myosin S1 and
actin density ratio obtained from the pellets separated on SDS gels. Vertical bars represent standard errors. Inset represents binding of the myosin S1 to native F-actin (closed
triangles) and F-actin−3 (open triangles).
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Fig. 6, indicate that when complexed with F-actin−3, smTM, TM2 and
TM1b9a inhibited the ATPase by a smaller degree than with native
actin. In turn, the degree of activation of the ATPase observed in the
presence of TM5a was grater for F-actin−3 than for native actin.
However, the differences between the short and long isoforms in the
degree of inhibition (or activation in the presence of TM5a) were not
signiﬁcant. This indicates that actin afﬁnity detected for short TM
isoforms in the S1-induced TM binding assay is not the major
determinant in the regulation of active cross-bridges.
4. Discussion
The purpose of this work was to elucidate the speciﬁc mechanism
(s) of TM-dependent thin ﬁlament regulation.We investigated the role
that the actin C-terminal region plays in interactionswith TM isoforms
and in the regulation of cross-bridge cycling. Because properties ofTable 2
Parameters of myosin S1-induced binding of TM isoforms to native and truncated actin
TM isoform: Half maximal saturationa
Native F-actin F-actin−3
smTM 0.20±0.02 (1.4) 0.19±0.01 (1.3)
TM2 0.22±0.02 (1.5) 0.22±0.04 (1.5)
TM1b9a 0.15±0.02 (0.9) 0.07±0.01 (0.4)
TM5a 0.19±0.01 (1.1) 0.08±0.02 (0.5)
a Half maximal saturation represents S1/actin molar ratio required for 50% saturation
of actin ﬁlaments with TM under the conditions of each experiment. The numbers were
obtained by ﬁtting experimental points to Eq. 3, as described in Materials and methods.
In parenthesis-S1/TM molar ratio obtained by multiplying S1/actin by the number of
actin monomers binding to 1 TM molecule (i.e. 7 for long TMs and 6 for short TMs).
Conditions: 5 mM imidazole, pH 7.0, 30 mM (or 12 mM for TM5a) NaCl, 0.5 mM MgCl2,
1 mM DTT.actin devoid of three C-terminal residues are well characterized, we
used thismodiﬁcation to study interactions between actin and TM, the
two major components of the thin ﬁlament.
In actin the C-terminal segment is located in subdomain 1. In the
ﬁlament it forms intermonomer contacts with subunits along and
across the ﬁlament [38]. Due to destabilization of the monomer–
monomer interface, the ﬁlaments assembled from C-terminal trun-
cated actin appear more ﬂexible [24]. In F-actin−3 changes in
conformation of the DNase I-binding loop in subdomain 2 and within
a segment comprising residues 227–235 of subdomain 4 were
observed [26]. In addition to intermonomeric contacts, the actin C-
terminus is connected to subdomains 1 and 2, as well as the
nucleotide-binding site of the same monomer [25,39].
We demonstrated that binding of smooth muscle and non-muscle
TM isoforms to actin alone was affected by C-terminal truncation. This
observation contrasts with our earlier ﬁnding of binding of striated
muscle TM to F-actin−3, which has been shown to be indistinguishable
from binding to native actin [15]. This suggests that the contact sites
on actinwith the isoforms of TM used in this study differ from those of
striated TM. These results are in agreement with electron microscopy
studies, in which TM isoforms were shown to can assume different
positions on the surface of the ﬁlament [40].
Why is skeletal TM binding neutral to the structural changes in the
ﬁlament caused by C-terminal truncation? The only sequence
difference between skeletal TM and non-muscle TM2 is the 27
amino acid long C-terminal segment encoded respectively by exons 9a
and 9d [2]. Since the 9d-encoded C-terminus is also present in smTM
and in TM5a, onemight suppose that the different binding is related to
this sequence. However, this is not the case, as we observed that
TM1b9a binding was also sensitive to C-terminal truncation. In this
chimeric protein striated muscle-speciﬁc C-terminus and N-terminus
present in short non-muscle isoforms are combined. The overlap
between 1a and 9a-encoded sequences differentiates skeletal TM from
Fig. 5. Double reciprocal plot of S1 MgATPase activity versus actin (open symbols)
and actin–TM (closed symbols) concentration. The regulation by TM5a (A) and TM2
(B) in the presence of native F-actin (circles) and F-actin−3 (triangles) was measured
in 5 mM imidazole pH 7.0, 30 mM NaCl, 2 mM MgCl2, 1 mM DTT at 0.38 μM S1. The
data were averaged from 4 experiments. The lines show linear regressions for each
set of averaged points.
Table 3
Summary of the effect of actin truncation on the regulation of myosin S1 ATPase by
different TM isoforms
TM isoform: Native F-actin F-actin−3
KM
b Vmax
a KM
b Vmax
a
Unregulated (34) 45.5±10.7 1.01±0.32 44.1±9.5 0.77±0.33
smTM (10) 40.2±10.9 0.54±0.24 41.2±13.2 0.54±0.27
TM2 (4) 46.0±10.9 0.72±0.12 47.0±12.1 0.59±0.33
TM1b9a (5) 49.8±8.5 0.50±0.12 48.2±12.1 0.46±0.15
TM5a (4) 47.4±12.9 1.38±0.49 45.5±9.2 1.18±0.43
The data are averages from the number of measurements given in parenthesis±SE.
a μmol Pi/mg S1/min.
b μM.
Fig. 6. Effect of actin C-terminal truncation on the regulation of actin-activated myosin
S1 MgATPase. The normalized acto-S1 ATPase activities are the maximal rates (Vmax)
divided by the activity with unregulated native F-actin (open bars) or F-actin−3
(hatched bars). Error bars are SE.
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residues from both ends of neighboring TM molecules form a
complex, which is thought to correctly align and orient TM on actin
[41]. Therefore, it appears that the nature of the overlap complex is
important for the location of TM on actin.
Analysis of the binding data according to the linear lattice model
[33] revealed additional information regarding the association of TM
isoforms with actin. For each isoform of TM that was analyzed, actin
truncation changed ω, the parameter which is linked to cooperativity
between adjacent TM molecules. This supports the idea that distant
conformational changes transmitted along actin participate in the
cooperativity of TM binding [14,42]. The way structural alterations
within the C-terminal region of actin affect TM binding depends on
the isoform of TM. The decrease of the actin afﬁnity is due to either
reduced binding to an isolated site, with no adjacent binding of TM
molecules, or it is due to reduced binding cooperativity. This may
indicate that the speciﬁc localization of TM on the ﬁlament
determines not only direct TM–actin interactions but also more
distant conformational changes within the ﬁlament.
When myosin heads are bound strongly to actin, the strands of TM
are shifted towards the inner domain of the ﬁlament [18,40]. Thus, an
allosteric change in subdomain 4 (e.g. the segment comprising
residues 227–235) associated with C-terminal truncation can con-
tribute to the binding of TM. Differential interactions of skeletal and
cardiac isoforms of TM with actin ﬂuorescently labeled in subdomain
4 were observed by Rubenstein and collaborators [6]. Here we have
shown that the cooperativity of S1-induced TM binding to truncated
actin depends on the isoform of TM. The isoforms that are neutral toactin truncation in the S1-induced binding assay (smTM and TM2),
share ends with the same sequences encoded by exons 1a and 9d. This
suggests that the 1a9d complex present in long TMs drives a speciﬁc
location on the ﬁlament, such that the distortion of actin structure
does not affect myosin S1-induced binding of these isoforms. All other
combinations of the ends result in TMs that are responsive to the
conformational changes associated with C-terminal modiﬁcation.
If the high afﬁnity of TM to the active state were the major
determinant of the cross-bridge activity, then the inhibition of the
ATPase should be much reduced in the presence of the TM isoforms,
which bind more easily to S1-activated F-actin−3, than with the
isoforms, which show no sensitivity to actin truncation in S1-induced
binding. The comparison of the isoforms (Fig. 6) shows no such
correlation. Recently published data support our results by showing
that the regulation of actomyosin activity is inﬂuenced by the
sequence and ﬂexibility of certain TM regions rather than by afﬁnity
of TM to actin in different states of activation [43,44].
In summary, isoforms of TM are able to detect conformational
changes in actin. For this function a speciﬁc combination of the ends,
which form an end-to-end overlap complex, is required. For binding to
actin alone all combinations of sequences encoded by exons 1a, 1b, 9a,
and 9d were sensitive to conformational changes in actin structure
associated with C-terminal truncation, except for the overlap 1a9a
found in skeletal TM. For the binding of TM in the myosin-induced
state only non-muscle isoforms with overlap sequence 1a9d were
insensitive to actin conformational changes. The native structure of
the actin C-terminus is important for actin-myosin interactions as it
keeps the ﬁlament in a more inhibited state. The increase in TM
afﬁnity to actin associated with the transition into a myosin-induced
state does not seem to play a major role in this process. The data
shown here support the idea that actin conformational changes can
differentially drive TM isoforms to speciﬁc cellular structures.
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